Certain individuals with cancer were significantly more likely to survive if they received a COVID-19 mRNA vaccine, researchers at the University of Texas MD Anderson Cancer Center reported. This ...
AUSTIN (KXAN) — Cancer researchers have a new tool at their disposal that could help improve survival rates. Developed by University of Texas undergraduate student Milit Patel, this new system gathers ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results